Specific Diagnostics Receives Investment from Telegraph Hill Partners to Commercialize Critical Drug Susceptibility Technology for Clinical Microbiology Labs

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2N0n9Do
via IFTTT